Evidence map›Paper›PMID 32528050›Full record

ArticleScientific reports2020

Molecular and Histopathological Study on the Ameliorative Impacts of Petroselinum Crispum and Apium Graveolens against Experimental Hyperuricemia.

Mohamed Mohamed Soliman, Mohamed Abdo Nassan, Adil Aldhahrani, Fayez Althobaiti, Wafaa Abdou Mohamed

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. High Flavonoid Content inPharmaceutical nanotechnology · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Journal of traditional and complementary medicine · 2022
    Article
  11. Impact ofNutrients · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mohamed Mohamed SolimanClinical Laboratory Sciences Department, Turabah University College, Taif University, Turabah, 29541, Saudi Arabia. mohamed.soliman@fvtm.bu.edu.eg.
Mohamed Abdo NassanPathology Department, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Adil AldhahraniClinical Laboratory Sciences Department, Turabah University College, Taif University, Turabah, 29541, Saudi Arabia.
Fayez AlthobaitiDepartment of Biotechnology, Faculty of Science, Taif University, Taif, Saudi Arabia.
Wafaa Abdou MohamedClinical Pathology Department, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Taif University · SAZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperuricemia is an abnormal metabolic condition characterized by an increase in uric acid levels in the blood. It is the cause of gout, manifested by inflammatory arthritis, pain and disability. This study examined the possible ameliorative impacts of parsley (PAR) and celery (CEL) as hypouricemic agents at biochemical, molecular and cellular levels. PAR and CEL alone or in combination were orally administered to hyperuricemic (HU) mice and control mice for 10 consecutive days. Serum levels of uric acid and blood urea nitrogen (BUN), xanthine oxidase activity, antioxidants, inflammatory (IL-1β and TNF-α) and anti-inflammatory cytokines (IL-10) were measured. mRNA expression of urate transporters and uric acid excretion genes in renal tissues were examined using qRT-PCR (quantitative real time PCR). Normal histology and immunoreactivity of transforming growth factor-beta 1 (TGF-β1) in kidneys was examined. Administration of PAR and CEL significantly reduced serum BUN and uric acids in HU mice, ameliorated changes in malondialdehyde, catalase, and reduced glutathione, glutathione peroxidase (GPX), IL-1β, TNF-α and IL-10 in hyperuricemic mice. Both effectively normalized the alterations in mURAT-1, mGLUT-9, mOAT-1 and mOAT-3 expression, as well as changes in TGF-β1 immunoreactivity. Interestingly, combined administration of PAR and CEL mitigated all examined measurements synergistically, and improved renal dysfunction in the hyperuricemic mice. The study concluded that PAR and CEL can potentially reduce damaging cellular, molecular and biochemical effects of hyperuricemia both individually and in combination.

Indexed as

AnimalsApiumBlood Urea NitrogenCytokinesGene Expression RegulationHyperuricemiaKidneyLiverMaleMiceOxidative StressPetroselinumPlant ExtractsRNA, MessengerXanthine OxidaseCytokinesPlant ExtractsRNA, MessengerXanthine Oxidase

Identifiers

PMID32528050
PMCPMC7289838
OpenAlexW3034499620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.